ImmunityBio, Inc.ImmunityBio, Inc.ImmunityBio, Inc.

ImmunityBio, Inc.

No trades
See on Supercharts

ImmunityBio, Inc. stock forum


IBRX Pharmaceutical companies will increase their profits and increase their income 1000%

IBRX Donald Trump's approach to using import restrictions to lower drug prices highlights the ongoing tension between the US and global pharmaceutical companies. With the US being the largest market for big pharma, this move could significantly impact the sector, particularly in countries like Ireland, where a substantial portion of exports is tied to the pharmaceutical industry. So US Medicines factories flourish and their profits rises

$IBRX. UK Approval adding to US approval of Anktiva for Bladder Cancer

IBRX Boral Capital has this at a buy with a target of $30. Are they serious?



IBRX hold your balls. don't sell lol

IBRX I thought this would pump by now given the revenue growth and analyst's valuations. Let's see what happens next week?


IBRX completes GMP drug substance manufacturing for 170k doses with 400k sq ft facility to produce 1m doses/year in 12-18 months. looks pretty good